NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced study data demonstrating that use of its Endo Stitch™ automated suturing device lowers mean hospital costs and operating room (OR) time during total laparoscopic hysterectomies treating benign conditions.
